Purpura fulminans: MRSA sepsis compounded by diclofenac

Mahym Mansoor*, Wajieha Saeed, Faria Altaf, Ijaz Hussain, Farwa Nasir Khan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Purpura fulminans is a rare, albeit a life-threatening emergency which has been reportedly triggered by infections, congenital disorders of protein C or S deficiencies, as well as drugs. Here we report a case of a previously healthy 17 year old male who developed purpura fulminans after fever, sore throat and then getting injection diclofenac. Blood cultures grew Staph. aureus. This case is the first to report two causative etiologies in a single patient.

Original languageEnglish
Pages (from-to)1780-1782
Number of pages3
JournalJournal of Pakistan Association of Dermatologists
Issue number4
StatePublished - Oct 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023 Pakistan Association of Dermatologists. All rights reserved.


  • MRSA, Diclofenac
  • Purpura fulminans

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Purpura fulminans: MRSA sepsis compounded by diclofenac'. Together they form a unique fingerprint.

Cite this